The global non-invasive cancer diagnostics market is witnessing substantial growth as healthcare providers increasingly prioritize early cancer detection, accurate diagnosis, and patient-friendly testing procedures. Non-invasive cancer diagnostics include liquid biopsy, molecular diagnostics, biomarker testing, genomic profiling, and advanced imaging technologies that help identify and monitor...